← Clinical & Translational Immunology
Papers in Clinical & Translational Immunology
Page 1 · newest first
- Staphylococcus aureus ‐derived xanthine exacerbates allergic rhinitis‐induced olfactory dysfunction through promoting Th17 cell differentiation and IL ‐ 17A productionClinical & Translational Immunology · 2026
- Parallel processing of T cells and natural killer cells to enhance in vivo CAR T cell activity against blood and solid cancersClinical & Translational Immunology · 2026
- Humoral and cellular responses to SARS‐CoV‐2 variants after ancestral COVID‐19 vaccines in people with HIV and lung transplant recipientsClinical & Translational Immunology · 2026
- Peripheral immune dynamics during treatment predict prognosis in HCC receiving TACE plus ICIs and anti‐ VEGF / TKIsClinical & Translational Immunology · 2026
- High IL ‐10 levels during CRS are negatively associated with NK ‐cell recovery after CAR ‐T cell therapyClinical & Translational Immunology · 2026
- Early brain‐penetrant immunotherapy reverses interferon signature and improves motor outcome in a case of ADAR1 ‐related Aicardi‐Goutières syndromeClinical & Translational Immunology · 2026
- Effect of CXCR5, PD‐1 and ICOS on B‐cell responses and relevance to myasthenia gravisClinical & Translational Immunology · 2026
- Development and functional adaptation of intestinal macrophages across the lifespanClinical & Translational Immunology · 2026
- Single‐cell and repertoire profiling reveals immune remodelling in paediatric upper airway: insights from adenoid hypertrophyClinical & Translational Immunology · 2026
- Control of poorly immunogenic tumors with systemic STING agonist‐loaded liposomes targeting cross‐presenting dendritic cellsClinical & Translational Immunology · 2026
- Alterations of circulating innate lymphoid cells in recent‐onset type 1 diabetesClinical & Translational Immunology · 2026
- Myeloid HDAC7 drives liver inflammation and systemic glucose dysregulation during diet‐induced obesityClinical & Translational Immunology · 2026
- Aberrant intra‐epithelial lymphocytes cause enterocyte cell death in refractory celiac disease by CD103 ‐β7‐receptor‐mediated granzyme‐B degranulation which can be restored by etrolizumabClinical & Translational Immunology · 2026
- Characterisation of tumor‐infiltrating gamma‐delta T cells in human colorectal cancer with MHC‐I lossClinical & Translational Immunology · 2026
- A novel case of autosomal recessive CARD11 loss‐of‐function underlying impaired antiviral immunity and a review of literatureClinical & Translational Immunology · 2026
- Enhanced Fc and complement activity of Fc‐modified avelumab boosts anti‐tumor activity but promotes NK cell fratricideClinical & Translational Immunology · 2026
- Seropositivity against rubella virus envelope protein 1, but not 2, is associated with an increased risk of multiple sclerosisClinical & Translational Immunology · 2026
- Neutralising antibody responses to emerging SARS ‐ CoV ‐2 omicron sub‐variants are enhanced in persons with hybrid immunityClinical & Translational Immunology · 2026
- Fatty acid metabolism—an emerging regulatory node in T‐cell immunometabolismClinical & Translational Immunology · 2026
- Spatial omics for profiling the dynamic tumor microenvironmentClinical & Translational Immunology · 2026
- A characterisation of the immune cells in immunocompetent and immunodeficient mice with orthotopic brain tumorsClinical & Translational Immunology · 2026
- Immunological insights into gastric polyps: pathogenesis, inflammation and neoplastic potentialClinical & Translational Immunology · 2026
- Spatial transcriptomic analysis of the immune landscape following NBUVB treatment of vitiligo skinClinical & Translational Immunology · 2026
- Helminths as architects of trained tolerance: implications for human healthClinical & Translational Immunology · 2026
- An Ad26‐ MVA ‐ BN ‐based therapeutic vaccine targeting HPV16 and HPV18 related disease is immunogenic in preclinical models and in women with persistent HPV infectionsClinical & Translational Immunology · 2026
- cGAS inhibitor IMSB301 modifies interferon signalling in peripheral mononuclear cells of SAMHD1 genetic interferonopathy in vitroClinical & Translational Immunology · 2026
- Adaptive immune response to the autoantigen LL ‐37 differentiates atherosclerotic cardiovascular disease phenotypesClinical & Translational Immunology · 2026
- Clinical, biological and cytometric characteristics of two patients with a homozygous A91V PRF1 mutationClinical & Translational Immunology · 2026
- Unveiling the immune landscape and microenvironmental architecture of IgA nephropathy using single‐cell imaging mass cytometryClinical & Translational Immunology · 2026
- Integration of single‐cell and bulk transcriptomics reveals the association of manganese metabolism‐related genes with prognosis and immune infiltration in lung adenocarcinomaClinical & Translational Immunology · 2026
- Influenza virus infection drives upregulation of CD84 across a broad range of immune cellsClinical & Translational Immunology · 2026
- Gut metabolites identified in cerebrospinal fluid of genetic interferonopathy support gut–brain endothelial dysfunctionClinical & Translational Immunology · 2026
- CD56 bright NK cells are negatively associated with antibody response to vaccination in people with multiple sclerosis on B‐cell‐depleting therapyClinical & Translational Immunology · 2026
- The impact of B‐cell reconstitution on mRNA vaccine responses in allogeneic stem cell transplant recipientsClinical & Translational Immunology · 2026
- Integrating mass spectrometry‐based multi‐omic signatures of extracellular vesicles: from discovery to clinical translationClinical & Translational Immunology · 2026
- A comprehensive analysis of the correlation between plasma cytokines/chemokines and tumor immune microenvironment signature influences the response of checkpoint inhibitors in advanced non‐small‐cell lung cancerClinical & Translational Immunology · 2026
- A novel surface plasmon resonance approach to assess anti‐dsDNA antibody kinetics and disease severity in systemic lupus erythematosusClinical & Translational Immunology · 2026
- Prolonged persistence of tissue‐resident memory cells in the upper airway following SARS ‐ CoV ‐2 infection and vaccinationClinical & Translational Immunology · 2026
- Dissecting infant and maternal antibody repertoires exposes the early onset of infant humoral immunityClinical & Translational Immunology · 2026
- CD4 ⁺ T‐cell responses directed towards A/H5N1‐derived haemagglutinin peptides increase in patients with seasonal influenza A virus infectionClinical & Translational Immunology · 2026
- Immune activation and response dynamics of human iPSC ‐derived macrophages in tuberculosis infection modelsClinical & Translational Immunology · 2026
- Nalmefene enhances the remyelinating ability of nalfurafine when administered therapeutically at very low doses during experimental autoimmune encephalomyelitisClinical & Translational Immunology · 2025
- Adeno‐associated viral vectors encoding anti‐P2X7 nanobodies reduce graft‐versus‐host disease in a humanised mouse modelClinical & Translational Immunology · 2025
- Genome‐wide association study and polygenic risk scores of eosinophilia in TaiwanClinical & Translational Immunology · 2025
- Lack of immunogenicity for an influenza‐derived peptide across the HLA‐B44 supertype moleculesClinical & Translational Immunology · 2025
- Long‐term effects of influenza and Bacille Calmette–Guérin vaccination on systemic inflammationClinical & Translational Immunology · 2025
- Elucidating novel immune profiles for predicting infection in high‐risk cohorts: a pilot study in patients with relapsed and refractory chronic lymphocytic leukaemiaClinical & Translational Immunology · 2025
- Optimised modular anti‐FLAG CAR T cells for solid tumor therapyClinical & Translational Immunology · 2025
- High‐dimensional spectral cytometry identifies follicular regulatory CD8 ⁺ T cells in diffuse large B‐cell lymphomaClinical & Translational Immunology · 2025
- Leveraging radiotherapy to improve immunotherapy outcomes: rationale, progress and research prioritiesClinical & Translational Immunology · 2025